IVD in India

 
   Single User - $4,200
   Site License (one location, 10 users) - $6,300
   Corporate License - $8,400



Loading...
Published Jan 6, 2016 | 240 Pages | Pub ID: KLI5819260

IVD in India

With a population of more than 1 billion, India is the world’s second largest country and therefore also a significant potential market for IVD (in vitro diagnostics) instruments and services. India has the world’s seventh-largest economy by nominal GDP and third largest by purchasing power parity. The country is one of the G-20 major economies with approximately 7% average growth rate for the last two decades. In the final quarter of 2014, India became the world's fastest growing major economy, replacing China.

As an IVD market, India leads the emerging nations and follows only the populous, developed economy markets of the United States, western European countries, Japan and China. The country and its healthcare system are confronted by challenges shared by the developing countries, as well as rising rates of diabetes, cardiovascular disease, and the diseases of aging.

Kalorama Information's report, IVD in India, places India and its market for in vitro diagnostics services in context with the developing world in terms of diseases, economic and healthcare system development, and other key metrics related to health expenditures and diagnostics. India as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over the past decade – Brazil, Russia and China.

India Diagnostic Market Trends and Forecasts

IVD in India presents current analysis of the Indian in vitro diagnostics industry and provides market forecasts to 2025. The report takes an in-depth look at the IVD market, providing data on the size and growth of the total Indian IVD market as well as on the following IVD market segments in India:
  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Point of Care/OTC
  • Molecular
  • Urinalysis
  • Other IVD Tests
IVD in India features a ten year forecast period, with projections of the total Indian IVD market and its component segments from 2015-2025, including:
  • Total IVD Sales in India, 2015-2025
  • IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
  • IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2020
  • IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2025
IVD in India presents the main issues and trends affecting the Indian IVD market, influencing its move into the future. Some of these include:
  • The Future of Indian Economic Growth
  • Market Segment Opportunities
  • BRIC Metrics – Indian IVD Market in Context
  • IVD Spending
  • Strengths – Conditions That Support Market Growth
  • Weaknesses – Factors That Pose Barriers to Market Success and Entry
  • Opportunities – Rural Healthcare and Technology Partnerships
  • Threats – Domestic and Chinese Competition
The report provides detailed information regarding the IVD services industry and company activity in India, noting market leaders and the recent activity of Indian IVD players and international IVD companies in India. 

In Vitro Diagnostics Companies Include:

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Alere
  • Arkray
  • Beckman Coulter, Inc./Danaher
  • Becton, Dickinson & Co.
  • Biohit Oy
  • bioMérieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Daan Gene Co., Ltd.
  • Danaher Corp.
  • Gen-Probe, Inc.
  • Grifols
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • Laboratory Corporation of America
  • Luminex Corporation
  • MedMira
  • Mindray Medical International, Ltd.
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Promega Corporation
  • QIAGEN N.V.
  • Quest Diagnostics
  • Radiometer A/S
  • Roche
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Shanghai Kehua Bio-engineering
  • Siemens
  • SRL Diagnostics
  • Sysmex Corp.
  • Thermo Fisher Scientific

Report Methodology


Information for this report was gathered from a wide variety of published sources including company reports, catalogs, materials and public filings; government documents; trade journals; newspapers and business press; analysts’ reports and other sources. Interviews with industry experts were conducted to capture the perspectives from market participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis. Sales estimates are provided for the 2015 base year and forecasts are provided through 2025. The size of each market segment refers to manufacturers’ revenues in U.S. dollars.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.